Novo Nordisk and Heartseed Partner for Heart Failure Stem Cell-based Therapy
Danish multinational pharmaceutical company Novo Nordisk and Japanese cardiac regenerative medicine specialist Heartseed have confirmed an exclusive global partnership and license
Read more